1. OP28 A randomized placebo controlled clinical trial with 5-hydroxytryptophan in patients with quiescent Inflammatory Bowel Disease and fatigue (Trp-IBD). (21st January 2022) Authors: Truyens, M; Lobaton, T; Peeters, A; Ferrante, M; Vermeire, S; Bossuyt, P; Pouillon, L; Dewint, P; Cremer, A; Peeters, H; Lambrecht, G; Louis, E; Rahier, J F; Dewit, O; Muls, V; Holvoet, T; Vandermeulen, L; Gonzales, G B; Laukens, D; De Vos, M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P131 Effectiveness and safety of vedolizumab maintenance therapy for inflammatory bowel disease: findings from a Belgian registry. (25th January 2019) Authors: Louis, E; Muls, V; Bossuyt, P; Colard, A; Nakad, A; Baert, D; Mana, F; Caenepeel, P; Vanden Branden, S; Vermeire, S; D'Heygere, F; Strubbe, B; Cremer, A; Coche, J-C; Setakhr, V; Baert, F; Vijverman, A; Coenegrachts, J L; Flamme, F; Hantson, A Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P527 Investigating fatigue in vedolizumab-treated patients with ulcerative colitis or Crohn's disease from a Belgian registry. (27th May 2021) Authors: Louis, E; Muls, V; Bossuyt, P; Colard, A; Nakad, A; Baert, D; Mana, F; Caenepeel, P; Vanden Branden, S; Vermeire, S; D'Heygere, F; Strubbe, B; Cremer, A; Setakhr, V; Baert, F; Vijverman, A; Coenegrachts, J L; Flamme, F; Hantson, A; Bennett, D Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S503 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P603 Persistence of vedolizumab maintenance therapy: Findings from a Belgian registry. (15th January 2020) Authors: Louis, E; Muls, V; Bossuyt, P; Colard, A; Nakad, A; Baert, D; Mana, F; Caenepeel, P; Vanden Branden, S; Vermeire, S; D'Heygere, F; Strubbe, B; Cremer, A; Coche, J C; Setakhr, V; Baert, F; Vijverman, A; Coenegrachts, J L; Flamme, F; Hantson, A Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S503 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P723 Effectiveness and persistence of vedolizumab in patients with Inflammatory bowel Disease: Results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE). (16th January 2018) Authors: Reenaers, C; Cremer, A; Dewit, O; de Vroey, B; Van Moerkercke, W; Bossuyt, P; Muls, V; Imschoot, J; Block, S; Hantson, A; Van Hootegem, P Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P842 SARS-CoV-2 antibody titers analysis in immune mediated inflammatory disease patients after COVID-19 vaccination: a monocentric retrospective study. (30th January 2023) Authors: Delaleeuwe, I; Aoun, J; Hoyois, A; Brasseur, C; Di Romana, S; Muls, V Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i968 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗